BLITZ Heart Failure
- Conditions
- Heart Failure
- Registration Number
- NCT03661060
- Lead Sponsor
- Heart Care Foundation
- Brief Summary
To evaluate if Italian Cardiologists are treating Heart Failure (HF) patients according to International guidelines and if a structured educational program can improved their adherence.
- Detailed Description
Multicentre, cross-sectional, prospective, non-interventional, observational study designed to evaluate the level of adherence to current ESC guidelines recommendations in both acute and chronic HF patients enrolled in each participating center and to verify if a specific HF educational intervention composed by an educational web based program of data collection and face to face meetings is able to improve adherence to guidelines recommendations evaluated during a second enrollment period.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7569
- All consecutive patients with chronic HF and those admitted for acute (de novo) or worsening chronic HF.
- Chronic HF: any NYHA class (I-IV).
- Acute HF Only patients in NYHA class III or IV, or with pulmonary edema or cardiogenic shock for whom an IV therapy specific for HF (diuretic, vasodilators, vasopressors) is administered.
- Any gender.
- Any etiology of HF.
- Any level of EF.
- Written informed consent.
-
- Age <18 years.
- Inclusion in registries or trials that can influence, by protocol, the clinical management of patients.
- Patients already enrolled in the BLITZ HF (by another participating centre or in the first enrollment period).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence to current guideline Enrollment To assess number of patients managed and treated following the 2016 ESC Heart Failure Gudelines (acute HF, chronic HFrEF, chronic HFmrEF, chronic HFpEF).
Patients managed and treated following International Guideline 24 months Patients treatment in phase 1 versus phase 3
- Secondary Outcome Measures
Name Time Method Mortality 12 months Follow-up Death from all-causes, for cardiovascular causes, for HF
Morbidity 12 months Follow-up Hospital admissions from all-causes, for cardiovascular causes, for HF
Indication to heart failure device implantation Enrollement The rate of patients with chronic HFrEF with an indication to ICD and/or CRT planned in clinical practice
Prescription rate of disease modifying drugs Enrollment The rate of patients with HFrEF receiving all the drugs recommended by current guidelines: ACE-Is/ARBs, betablockers and MRAs, in the absence of specific contraindications/intolerance.
Oral anticoagulation prescription in patients with AF Enrollment Rate of patients treated with oral anticoagulants in case of AF
Use of ARNI Enrollment The rate of implementation of a new drug approach (ARNI) for patients with HF and EF ≤35%
Creatinine and EF evaluation Enrollment The rate of CHF patients with an available measure of EF and of creatinine.
Trial Locations
- Locations (122)
Ospedali Riuniti - Sod Cardiologia Ospedaliera Emod. E Utic
🇮🇹Ancona, AN, Italy
Ospedale Generale Regionale-Po U. Parini - U.O. Cardiologia E Cure Intensive Card.
🇮🇹Aosta, AO, Italy
Ospedale Gen.Le Prov.Le C.G. Mazzoni - Sc Cardiologia
🇮🇹Ascoli Piceno, AP, Italy
Ospedale Valdichiana Santa Margherita - Uos Cardiologia E Hdu
🇮🇹Cortona, AR, Italy
Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti'
🇮🇹Avellino, AV, Italy
Asst Papa Giovanni Xxiii - Cardiologia 1
🇮🇹Bergamo, BG, Italy
Ospedale Bolognini - Cardiologia E Unita' Coronarica
🇮🇹Seriate, BG, Italy
Ospedali Treviglio-Caravaggio - Cardiologia
🇮🇹Treviglio, BG, Italy
Ospedale Santa Maria Del Prato - U.O. Di Cardiologia
🇮🇹Feltre, BL, Italy
Ospedale Maggiore - U.O. Di Cardiologia
🇮🇹Bologna, BO, Italy
Scroll for more (112 remaining)Ospedali Riuniti - Sod Cardiologia Ospedaliera Emod. E Utic🇮🇹Ancona, AN, Italy